Item 3 is hereby amended and supplemented as follows: On June 30, 2026, the Issuer issued an aggregate of 13,619,377 shares of Common Stock to OC III LFE in accordance with OC III LFE's partial exercise of certain warrants (the "Partial Exercises"). In particular, OC III LFE partially exercised (a) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of October 13, 2020 (the "2020 Warrant"), to purchase a number of shares of Common Stock equal to 22.99% of the Common Stock Deemed Outstanding (as defined in the 2020 Warrant), (b) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of December 30, 2021 (the "2021 Warrant"), to purchase a number of shares of Common Stock equal to 4.99% of the Common Stock Deemed Outstanding (as defined in the 2021 Warrant), and (c) a warrant, which was originally issued pursuant to the terms of the warrant acquisition agreement, dated as of April 4, 2022 (the "2022 Warrant"), to purchase a number of shares of Common Stock equal to 4.99% of the Common Stock Deemed Outstanding (as defined in the 2022 Warrant). Each such share of Common Stock was purchased at a price of $0.01 pursuant to the respective net exercise provisions governing the warrants.

Item 4 is hereby amended and supplemented as follows: The Reporting Person's acquisition of the Common Stock to which this Statement relates was for investment purposes in the ordinary course of business. The Reporting Person acquired the Common Stock because they believed that the Common Stock reported herein, when purchased, represented an attractive investment opportunity. The Reporting Person and its representatives may engage in discussions with members of management of the Issuer and the board of directors of the Issuer (the "Board"), other current or prospective shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other third parties regarding a variety of matters relating to the Issuer, which may include, among other things, the Issuer's business, management, capital structure and allocation, shareholder rights plan, corporate governance, Board composition, transformation transactions and strategic alternatives and direction, and may take other steps seeking to bring about changes to increase shareholder value as well as pursue other plans or proposals that relate to or could result in any of the matters referred to in subparagraphs (a) - (j) of Item 4 of Schedule 13D. The Reporting Person intends to review its investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer's financial position, results and strategic discretion, actions taken by the Issuer's management and the Board, price levels of the Common Stock, other investment opportunities available to the Reporting Person, conditions in the securities market and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to its investment in the Issuer as they deem appropriate, including, without limitation, exchanging information with the Issuer or other third parties pursuant to appropriate confidentiality or similar agreements, proposing changes in the Issuer's operations, governance or capitalization, acquiring additional Common Stock and/or other equity, debt, notes, instruments or other securities of the Issuer (collectively, "Securities") or disposing of some or all of the Securities beneficially owned by them, in public market or privately negotiated transactions, entering into financial instruments or other agreements that increase or decrease the Reporting Person's economic exposure with respect to its investment in the Issuer and/or otherwise changing its intention with respect to any and all matters referred to in Item 4 of Schedule 13D. Except as set forth herein, the Reporting Person does not have present plans or proposals at this time that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

The responses of the Reporting Person to rows (11) through (13) of the cover pages of this Statement are incorporated herein by reference.

The responses of the Reporting Person to rows (7) through (10) of the cover pages of this Statement are incorporated herein by reference.

Except as described in Item 3 to this Amendment No. 9, there have been no transactions with respect to the Common Stock during the sixty days prior to the date of this Amendment No. 9 by the Reporting Person.

No person other than the Reporting Person, OC XXVIII, OC III, and OC III LFE is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock reported herein.

Not applicable.

Item 6 is hereby amended and supplemented as follows: The disclosure set forth in Item 3 of this Amendment No. 9 is incorporated herein by reference. On June 30, 2026, as a result of the Partial Exercises of the 2020 Warrant, the 2021 Warrant and the 2022 Warrant, the Issuer issued replacement warrants (in the case of the 2020 Warrant, the "Replacement 2020 Warrant"; in the case of the 2021 Warrant, the "Replacement 2021 Warrant"; and in the case of the 2022 Warrant, the "Replacement 2022 Warrant") entitling OC III LFE or its assigns to subscribe for and purchase from the Issuer the remaining unpurchased shares under the respective original warrants. The foregoing descriptions of the Replacement 2020 Warrant, the Replacement 2021 Warrant and the Replacement 2022 Warrant are qualified in their entireties by reference to the full texts of such warrants, the forms of which are included as Exhibits 99.1, 99.2 and 99.3, respectively, hereto and are incorporated by reference herein. On December 31, 2024, the Issuer redeemed all outstanding shares of Preferred Stock from the Purchaser and, thereafter, the Preferred Stock ceased to be outstanding. Except as set forth herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

Exhibit 99.1: Form of Replacement 2020 Warrant Exhibit 99.2: Form of Replacement 2021 Warrant Exhibit 99.3: Form of Replacement 2022 Warrant